Catapult Sports (ASX: CAT) posts record 27-28% ACV growth in FY26 trading update as dual acquisitions reshape the sports analytics platform
Read More 4 minute read Pharma Industry News Moleculin Biotech moves forward with pivotal Annamycin trial in AML after FDA backing Moleculin Biotech, Inc. (Nasdaq: MBRX), a late-stage pharmaceutical company focused on developing innovative treatments for acute myeloid leukemia,… byPallavi MadhirajuFebruary 13, 2025